Further Observations on the Endocrine Aspects of Argentaffinoma

Abrahams V. C. Pickford Mary (1956). The effect of 5-hydroxytryptamine on the excretion of water in conscious dogs. Brit. J. Pharmacol., 11, 35.

Asatoor A. Dalgliesh C. E. (1956). Isolation of aromatic substances using modified charcoals. Biochem. J., 62, 29.

Black J. W. Fisher E. W. Smith A. N. (1956). The effects of 5-hydroxytryptamine on acid gastric secretion. Proc. XXth Internat. Physiol. Cong., p. 102.

Bleehen N. M. (1955). Precipitation by fatty food of systemic disturbance from argentaffinoma. Lancet, 2, 1362.

Bonsnes R. W. Taussky H. H. (1945). On colorimetric determination of creatinine by the Jaffe reaction. J. biol. Chem., 158, 581.

Cerletti A. Rothlin E. (1955). Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature, Lond., 176, 785.

Dalgliesh C. E. (1955a). Isolation and examination of urinary metabolites containing an aromatic system. J. clin. Path., 8, 73.

Dalgliesh C. E. (1955b). Metabolism of the aromatic amino acids. Adv. Protein Chem., 10, 31.

Dalgliesh C. E. (1956). Two-dimensional paper chromatography of urinary indoles and related substances. Biochem. J. (in press).

Dalgliesh C. E. Toh C. C. Work T. S. (1953). Fractionation of the smooth muscle stimulants present in extracts of the gastrointestinal tarct. Identification of 5-hydroxytryptamine and its distinction from substance P. J. Physiol., 120, 298.

Daugherty G. W. Manger W. M. Roth G. M. Flock E. V. Childs D. S. Jr. Waugh J. M. (1955). Malignant carcinoid with hyperserotonemia occurring spontaneously or induced by palpation of the tumour or by intravenous histamine: Report of case. Proc. Mayo Clin., 30, 595.

Duncan D. Garven J. D. Gibbons J. L. (1955). Argentaffin carcinoma of ileum with raised serum 5-hydroxytryptamine: Report of a case. Brit. med. J., 2, 1586.

Erspamer V. (1954). Pharmacology of indolealkylamines. Pharmacol. Rev., 6, 425.

Erspamer V. Ottolenghi A. (1953). Pharmacological studies on enteramine. VIII. Action of enteramine on diuresis and the renal circulation of the rat. Arch. int. Pharmacodyn., ud, 177.

Feldberg W. Smith A. N. (1953). The release of histamine by tryptamine and 5-hydroxytryptamine. Brit. J. Pharmacol, 8, 406.

Goble A. J. Hay D. R. Sandler M. (1955). 5-hydroxytryptamine metabolism in acquired heart disease associated with argentaffin carcinoma. Lancet, 2, 1016.

Langemann H. (1955). 5-hydroxytryptamine (Serotonin)-a new hormone. Schweiz. med. Wschr., 85, 957.

Macfarlane P. S. Dalgliesh C. E. Dutton R. W. Lennox B. Nyhus L. M. Smith A. N. (1956). Endocrine aspects of argentaffinoma, with special reference to the use of urinary 5-hydroxyindoleacetic acid estimations in diagnosis. Scot. med. J., 1, 148.

McNeely R. G. D. Jones N. W. (1946). Secondary pellagra caused by multiple argentaffin carcinoma of the ileum and jejunum. Gastroenterology, 6, 443.

MEDICAL RESEARCH COUNCIL COMMITTEE ON CLINICAL ENDOCRINOLOGY (1951). Proposed standard method of 17-ketosteroid determination. Lancet, 2, 585.

Page I. H. (1954). Serotonin (5-hydroxytryptamine). Physiol. Rev., 34, 563.

Pernow B. Waldenstrom J. (1956). Increased urinary excretion of histamine in cases of carcinoid tumour. Proc. XXth Internat. Physiol. Cong., p. 718.

Roberts M. Adam H. M. (1950). New methods for the quantitative determination of free or conjugated histamine in body fluids. Brit. J. Pharmacol., 5, 529.

Rose W. C. Lambert C. F. Coon M. J. (1954). The amino acid requirements of man. VII. General procedures; the tryptophan requirement. J. biol. Chem., 211, 815.

Shore P. A. Silver S. A. Brodie B. B. (1955). Interaction of reserpine, 5-hydroxytryptamine and lysergic acid diethylamide in the central nervous system. Science, 122, 284.

Sircus W. (1954). Studies of uropepsinogen excretion in gastrointestinal disorders. Quart. J. Med., 91, 291.

Sjoerdsma A. Weissbach H. Udenfriend S. (1955). Simple test for the diagnosis of metastatic argentaffinoma. J. Amer. med. Ass., 159, 397.

Sjoerdsma A. Weissbach H. Udenfriend S. (1956). A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Amer. J. Med., 20, 520.

Sloan A. W. (1951). The normal platelet count in man. J. clin. Path., 4, 37.

Snow P. J. D. Lennard-Jones J. E. Curzon G. Stacey R. S. (1955). Humoral effects of metastasizing carcinoid tumours. Lancet, 1, 1004.

Thorson A. Biorck G. Bjorkman G. Waldenstrom J. (1954). Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis: A clinical and pathological syndrome. Amer. Heart J., 47, 795.

Toh C. C. (1954). Release of 5-hydroxytryptamine from the dog's gastrointestinal tract. J. Physiol., 126, 248.

Udenfriend S. Bogdanski D. F. Weissbach H. (1955). Fluorescence characteristics of 5-hydroxytryptamine. Science, 122, 972.

Udenfriend S. Weissbach H. Clark C. T. (1955). The estimation of 5-hydroxytryptamine (Serotonin) in biological tissues. J. biol. Chem., 125, 337.